fbpx
QQQ
+ 2.73
293.55
+ 0.92%
DIA
+ 0.63
297.96
+ 0.21%
SPY
+ 1.22
361.27
+ 0.34%
TLT
+ 1.54
157.14
+ 0.97%
GLD
-1.73
171.23
-1.02%

Marrone Bio Reports Q4 Earnings, Plans To Prioritize Cannabis Market

March 15, 2019 10:25 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Crop protection and plant health solutions company Marrone Bio Innovations Inc (NASDAQ:MBII) reported financial results for the fourth quarter and full year Thursday.

The Davis, California-based company posted fourth-quarter revenue of $5.7 million, up by 72 percent on the year.

The Cannabis Capital Conference is coming back to Toronto! Click here to learn how you can join Tim Seymour, Jon Najarian, Danny Moses, Alan Brochstein and many others.

What Happened

In addition to higher revenue, Marrone Bio Innovations narrowed its fourth-quarter net loss by 35 percent to $8 million. For the full year, the company's revenue increased by 17 percent to $21.2 million, while the net loss declined by 35 percent to $20.2 million. 

Marrone Bio Innovation also managed to expand its gross margin to 50.5 percent in the fourth quarter from 46 percent a year earlier. 

Why It's Important

The cannabis industry supplier said it is also focusing on expanding and optimizing its portfolio and launching into more international markets. Last quarter, Marrone launched TerraConnect, a soil-applied and seed-treatment platform that provides growers with high-performance products and tools to improve and protect crops. 

It also inked an agreement with Hop Tri Investment Corporation in Vietnam and Cambodia; AMC/Agrimatco in Turkey; and Kyung Nong Corporation in South Korea to distribute its products in these countries.

What's Next

Marrone Bio said it plans to prioritize cannabis and hemp through its Cultivated Garden portfolio.

Recently, the California Department of Pesticide Regulation completed the review of Venerate CG and approved it for the use on cannabis in the state. 

During the earnings call, Chief Commercial Officer Kevin Hammill said the company sees an opportunity in the U.S. hemp market because they believe their products are a good fit as hemp growers — especially those cultivating hemp for CBD extraction — are looking for low-residue, high-performing and low-impact products. 

Related Links:

Raymond James Raises PT On Scotts Miracle-Gro Following Q1 Earnings

Global Hemp, Poised To Make Its Impact With A Post-Industrial Heyday

Photo courtesy of Marrone Bio. 


Related Articles

CBD For Dogs: Do Vets Recommend It For Your Pets?

This article was originally published on WeedWeek, and appears here with permission. read more

The 9 Best Cannabis Podcasts To Listen To Right Now

This article was originally published on Cannabis & Tech Today, and appears here with permission. read more

Pure Sunfarms Inks Supply Deal With Shoppers Drug Mart

Pure Sunfarms opted to supply Shoppers Drug Mart Inc's customers with its cannabis products. The Village Farms International Inc. (NASDAQ: VFF) (TSX: VFF) subsidiary teamed up with the Canadian retail pharmacy chain to provide consumers with Pure Sunfarms' dried flower products. read more

Cannabis Movers & Shakers: Cannabis Growth Opportunity, Bhang, CanaFarma Hemp, Amfil Technologies

Here is a summary of the latest company shakeups within the cannabis industry. 3 Execs Exit Cannabis Growth Opportunity Investment company Cannabis Growth Opportunity Corporation (CSE: CGOC) has parted ways with several executives. read more

Hemp And CBD Media Outlet PuraPhy Expands To Functional Mushrooms And Psychedelics

This article was originally published on Microdose Psychedelic Insights and appears here with permission. read more